<bill session="117" type="h" number="2815" updated="2023-03-08T19:58:48Z">
  <state datetime="2021-04-22">REFERRED</state>
  <status>
    <introduced datetime="2021-04-22"/>
  </status>
  <introduced datetime="2021-04-22"/>
  <titles>
    <title type="display">BIOSIM Act</title>
    <title type="official" as="introduced">To amend title XVIII of the Social Security Act to provide for a temporary payment increase under the Medicare program for certain biosimilar biological products to encourage the development and use of such products.</title>
    <title type="short" as="introduced">BIOSIM Act</title>
    <title type="short" as="introduced">Bolstering Innovative Options to Save Immediately on Medicines Act</title>
  </titles>
  <sponsor bioguide_id="S001180"/>
  <cosponsors>
    <cosponsor bioguide_id="B001251" joined="2021-06-29"/>
    <cosponsor bioguide_id="K000378" joined="2021-04-22"/>
    <cosponsor bioguide_id="S001216" joined="2021-07-22"/>
    <cosponsor bioguide_id="S001207" joined="2021-06-29"/>
  </cosponsors>
  <actions>
    <action datetime="2021-04-22">
      <text>Introduced in House</text>
    </action>
    <action datetime="2021-04-22" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2021-04-22">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2021-04-22">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2021-04-22">
      <text>Referred to the Subcommittee on Social Security.</text>
    </action>
    <action datetime="2021-04-23">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
    <committee code="HSWM" name="House Ways and Means" subcommittee="" activity="Referral"/>
    <committee code="HSWM01" name="House Ways and Means" subcommittee="Social Security" activity="Referral"/>
    <committee code="HSWM02" name="House Ways and Means" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="117" type="h" number="7497" relation="unknown"/>
    <bill session="117" type="h" number="5376" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Health care costs and insurance"/>
    <term name="Medicare"/>
    <term name="Prescription drugs"/>
    <term name="Product development and innovation"/>
  </subjects>
  <amendments/>
  <summary date="2021-06-23T13:35:07Z" status="Introduced in House">Bolstering Innovative Options to Save Immediately on Medicines Act or the BIOSIM Act

This bill increases Medicare payments for biosimilars for five years. The bill applies to biosimilars for which the average sales price or wholesale acquisition cost is less than that of the reference biological product, as specified.</summary>
</bill>
